Additional Corrections: Interferon for Hemangiomas of Infancy

Abstract
Inaccuracies in our paper “Interferon Alfa-2a Therapy for Life-Threatening Hemangiomas of Infancy”1 prompted a careful review. On the basis of our reanalysis and an interim review by a standing faculty committee of the Harvard Medical School, we submitted a revised Table 1, published as a correction notice.2 The final review of this committee concluded that ambiguities in method, presentation, and conclusions should be clarified and that errors remained that should be corrected.

This publication has 2 references indexed in Scilit: